{
  "trial_id": "NCT02558725",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "diagnosis of IDA between 16-19 weeks",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "allocation were: deterioration in hemoglobin levels mandating IV iron administration, more than 3 capsules missed at the 2 weeks check-up, diarrhea lasting more than 5 days, vomiting lasting more than 5 days less than 2 hours after supplement ingestion",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Randomizer (http://www.randomizer.org) to receive either one or two capsules of aktiferrin F (containing DL-Serine 129 mg; Iron (Ferrous Sulfate) 34 mg; Folic Acid 0.5 mg) or Foliferrin (containing DL-Serine 120 mg; Iron (Ferrous Sulfate) 34 mg; Folic Acid 0.5 mg)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Participants were instructed to take one capsule at least 2 hours after consumption of dairy products or two capsules 12 hours apart at least 2 hours after consumption of dairy products",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Validation of compliance to medical regimens was performed by a count of empty pill packages every two weeks during regular check-ups",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "All participants were monitored for weight, BP and urine dipstick measurements every 2-3 weeks until 34 weeks",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Episodes of vomiting, constipation and diarrhea were recorded",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Constipation was defined as fewer than three bowel movements a week or bowel movements consisting of hard, dry and small stool, making it painful or difficult to pass",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Fetal BPP and estimated weight were performed every 2-3 weeks until 34 weeks of gestation",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Fetal monitor was performed every two weeks from 34 weeks of gestation",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Laboratory follow up was performed by measurements of ferritin and hemoglobin levels at fixed time intervals during gestation: 15-20 weeks, 24 weeks, 35 weeks and also 6 weeks post-partum",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "All lab studies were performed in a single central laboratory",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "gravidarum continuing past 20 weeks of gestation",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Thalassemia",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient is a 19-year-old Hispanic female with mild headache and leg swelling. She has no specific past medical issues, but her family history is positive for DM type 2 and HTN.",
  "_meta": {
    "topic_id": "42",
    "trial_id": "NCT02558725",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}